de Oliveira, Jaqueline Carvalho <br/><br/>
In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells.  [electronic resource] 

 -  Journal of drugs in dermatology : JDD  May 2012 
 - 587-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-9616 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>M Phase Cell Cycle Checkpoints--drug effects<br/>Melanoma--drug therapy<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Pteridines--administration & dosage<br/>Skin Neoplasms--drug therapy<br/>Polo-Like Kinase 1